Cleared Traditional

K171314 - QLAB Advanced Quantification Software

K171314 is an FDA 510(k) clearance for QLAB Advanced Quantification Software, manufactured by Philips Health Care. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 26-day FDA review.

K171314 · Philips Health Care · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2017
Decision
26d
Days
Class 2
Risk

K171314 is an FDA 510(k) clearance for the QLAB Advanced Quantification Software. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Philips Health Care (Andover, US). The FDA issued a Cleared decision on May 30, 2017 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Philips Health Care devices

FDA 510(k) Submission Details - K171314

510(k) Number K171314 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 04, 2017
Decision Date May 30, 2017
Days to Decision 26 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
81d faster than avg
Panel avg: 107d · This submission: 26d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1736
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K171314.
SmartTarget
K170250 · Smarttarget, Ltd. · Jun 2017
syngo Dynamics Version VA30
K171053 · Siemens Healthcare GmbH · Jun 2017
AmCAD-US
K162574 · Amcad Biomed Corporation · May 2017
vascuCAP
K163071 · Elucid Bioimaging, Inc. · May 2017
UNiD Spine Analyzer
K170172 · Medicrea International · May 2017
Dynamika
K161601 · Image Analysis Limited · May 2017